TAVR: Future of Cerebral Embolic Protection
Drs. Susheel Kodali, Samir Kapadia, Axel Linke, and Alexandra Lansky -discuss the latest updates on Cerebral Embolic Protection in TAVR
 |
|
|
PCSK9 antagonists-ESC 2016
PCSK9 antagonists: A real breakthrough for management of familial hypercholesterolaemia? ESC2016 -Professor Ulf Landmesser from Charite - Universitatsmedizin Berlin, Germany, speaks to Cardio Debate Radcliffe Cardiology about PCSK9 antagonists and if theres a real breakthrough for management of familial hypercholesterolaemia during the ESC2016 Congress held in Rome, Italy
|
|
|
Genetic markers in CV disease-ESC 2016
Perry Elliot, Professor of Inherited Cardiovascular Disease at University College of London, UK, speaks to Cardio Debate Radcliffe Cardiology about genetic markers in cardiovascular disease and discusses if there are major advances in the everyday practice, during the ESC2016 Congress held in Rome, Italy
|
|
|
New drugs for the management of heart failure-ESC2016
Professor Felipe Martinez from Universidad Nacional de Córdoba, Argentina, speaks to Cardio Debate Radcliffe Cardiology about the new drugs and treatments for the management of heart failure during the ESC2016 Congress held in Rome, Italy
| 1 2 | Next Page >> |
Aryanic webdesign توسط highportal aryanic